Ages2Come
Menu
View all results →
Categories
⚡ Breaking
Missouri Voters Appear to Recall City Councilman Over Data Center Support Japanese green tea giant Ito En surges 8%, defying a broad market sell-off Australia posts second-quarter growth of 2.1%, beating expectations Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group Massachusetts’ 80-year-old senator sees off primary challenge over his age Pentagon chaos deepens after Driscoll quits in clash with Hegseth Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics Missouri Voters Appear to Recall City Councilman Over Data Center Support Japanese green tea giant Ito En surges 8%, defying a broad market sell-off Australia posts second-quarter growth of 2.1%, beating expectations Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group Massachusetts’ 80-year-old senator sees off primary challenge over his age Pentagon chaos deepens after Driscoll quits in clash with Hegseth Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics
General

Amping up T cells to target cancer

Source: mitTechReview August 25, 2026 · 14:00
Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it—delivering the vaccine along with immune-stimulating molecules called cytokines—can…
Read original article ← Back to General

The original article opens on the publisher's website.

More from General

View topic →